Michael Egholm's most recent trade in Standard BioTools Inc was a trade of 9,906 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 28 May 2025 | 9,906 | 2,731,285 (3%) | 0% | 1.1 | 10,798 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 23 May 2025 | 5,473 | 2,741,191 (3%) | 0% | 0.9 | 5,150 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 22 May 2025 | 5,116 | 2,746,664 (3%) | 0% | 1.0 | 5,126 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.05 per share. | 20 May 2025 | 18,343 | 2,756,499 (3%) | 0% | 1.0 | 19,260 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 20 May 2025 | 4,719 | 2,751,780 (3%) | 0% | 1.0 | 4,861 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2025 | 196,512 | 196,513 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2025 | 196,512 | 2,832,518 (4%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.07 per share. | 04 Apr 2025 | 57,676 | 2,774,842 (3%) | 0% | 1.1 | 61,713 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 1,782,500 | 1,782,500 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 1,188,333 | 2,636,006 (3%) | 1% | 0 | Common Stock | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 20 Feb 2025 | 31,031 | 1,447,673 (2%) | 0% | 1.4 | 43,133 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.51 per share. | 20 Nov 2024 | 28,795 | 1,473,704 (2%) | 0% | 1.5 | 43,480 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 20 Aug 2024 | 29,093 | 1,502,499 (2%) | 0% | 1.9 | 55,568 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 2,250,000 | 2,250,000 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 1,000,000 | 1,531,592 (2%) | 1% | 0 | Common Stock | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.71 per share. | 08 Apr 2024 | 102,564 | 531,592 (0%) | 0% | 2.7 | 277,948 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 212,126 | 634,156 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 196,512 | 393,025 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 196,512 | 422,030 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 9,006 | 225,518 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2023 | 196,512 | 589,537 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2023 | 196,512 | 206,512 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 4,529,773 | 4,529,773 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 786,049 | 786,049 | - | - | Restricted Stock Units |